Facets (new session)
Description
Metadata
Settings
owl:sameAs
Inference Rule:
b3s
b3sifp
dbprdf-label
facets
http://dbpedia.org/resource/inference/rules/dbpedia#
http://dbpedia.org/resource/inference/rules/opencyc#
http://dbpedia.org/resource/inference/rules/umbel#
http://dbpedia.org/resource/inference/rules/yago#
http://dbpedia.org/schema/property_rules#
http://www.ontologyportal.org/inference/rules/SUMO#
http://www.ontologyportal.org/inference/rules/WordNet#
http://www.w3.org/2002/07/owl#
ldp
oplweb
skos-trans
virtrdf-label
None
About:
Déjà vu: Stimulating open drug discovery for SARS-CoV-2
Goto
Sponge
NotDistinct
Permalink
An Entity of Type :
schema:ScholarlyArticle
, within Data Space :
wasabi.inria.fr
associated with source
document(s)
Type:
Academic Article
research paper
schema:ScholarlyArticle
New Facet based on Instances of this Class
Attributes
Values
type
Academic Article
research paper
schema:ScholarlyArticle
isDefinedBy
Covid-on-the-Web dataset
title
Déjà vu: Stimulating open drug discovery for SARS-CoV-2
Creator
Andrade, Carolina
Coffee, Megan
Ekins, Sean
Mottin, Melina
Zorn, Kimberley
Braga, Rodolpho
Foil, Daniel
Southan, Christopher
Neves, Bruno
Puhl, Ana
Ramos, Paulo
Sousa, Bruna
source
Elsevier; Medline; PMC
abstract
In the past decade we have seen two major Ebola virus outbreaks in Africa, the Zika virus in Brazil and the Americas and the current pandemic of coronavirus disease (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). There is a strong sense of déjà vu because there are still no effective treatments. In the COVID-19 pandemic, despite being a new virus, there are already drugs suggested as active in in vitro assays that are being repurposed in clinical trials. Promising SARS-CoV-2 viral targets and computational approaches are described and discussed. Here, we propose, based on open antiviral drug discovery approaches for previous outbreaks, that there could still be gaps in our approach to drug discovery.
has issue date
2020-04-19
(
xsd:dateTime
)
bibo:doi
10.1016/j.drudis.2020.03.019
bibo:pmid
32320852
has license
no-cc
sha1sum (hex)
57743aceb2d3e286acc75f8e2610602e7061f911
schema:url
https://doi.org/10.1016/j.drudis.2020.03.019
resource representing a document's title
Déjà vu: Stimulating open drug discovery for SARS-CoV-2
has PubMed Central identifier
PMC7167229
has PubMed identifier
32320852
schema:publication
Drug Discov Today
resource representing a document's body
covid:57743aceb2d3e286acc75f8e2610602e7061f911#body_text
is
schema:about
of
named entity 'Ebola'
named entity 'PubChem'
named entity 'antivirals'
named entity 'antiviral'
named entity 'protein'
named entity 'ribavirin'
named entity 'darunavir'
named entity 'ACE2'
named entity 'antiviral'
named entity 'PDB'
named entity 'ritonavir'
named entity 'pathogenesis'
named entity 'SARS-CoV-2'
named entity 'genetic analysis'
named entity 'Zika'
named entity 'fosamprenavir'
named entity 'drug companies'
named entity 'genome sequences'
named entity 'Betacoronavirus'
named entity 'Zika'
named entity 'Ebola'
named entity 'Ebola'
named entity 'Zika'
named entity 'ritonavir'
named entity 'grazoprevir'
named entity 'MERS-CoV'
named entity 'SARS-CoV-2'
named entity 'Brazil'
named entity 'helicase'
named entity 'Brazil'
named entity 'ACE2'
named entity 'coronavirus'
named entity 'Zika'
named entity 'indinavir'
named entity 'anti-inflammatory drugs'
named entity 'kinase'
named entity 'drug discovery'
named entity 'pyronaridine'
named entity 'homology modeling'
named entity 'homology modeling'
named entity 'Spike protein'
named entity 'drug discovery'
named entity 'drug discovery'
named entity 'SARS-CoV'
named entity 'SARS-CoV'
named entity 'small molecule'
named entity 'polypharmacology'
named entity 'approved drugs'
named entity 'cost-effectiveness'
named entity 'SARS-CoV-2'
named entity 'artesunate'
named entity 'lopinavir/ritonavir'
named entity 'Zika'
named entity 'SARS-CoV-2'
named entity 'Zika'
named entity 'enzyme'
named entity 'Pyronaridine'
named entity 'Pymol'
named entity 'imatinib'
named entity 'quinacrine'
named entity 'binding pocket'
named entity 'empagliflozin'
named entity 'ombitasvir'
named entity 'virion'
named entity 'RNA synthesis'
named entity 'SARS-CoV-2'
named entity 'Ebola'
named entity 'hepatitis'
named entity 'genome'
named entity 'Germany'
◂◂ First
◂ Prev
Next ▸
Last ▸▸
Page 1 of 6
Go
Faceted Search & Find service v1.13.91 as of Mar 24 2020
Alternative Linked Data Documents:
Sponger
|
ODE
Content Formats:
RDF
ODATA
Microdata
About
OpenLink Virtuoso
version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software